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Abstract
Summary We examined the association between peripheral
arterial disease (PAD) and bone health in 1,332 adults. We
found a weak association between PAD and osteoporosis
and bone loss only in women, but the association was not
independent of age. PAD was not associated with fractures
in this community-based population.
Introduction Increased rates of osteoporosis have been
reported in patients with cardiovascular disease, suggesting
a link between osteoporosis and atherosclerosis.
Methods We examined the association between PAD and
bone health in 1,332 adults who attended a research visit in
1992–1996, when the ankle–brachial index (ABI), bone
mineral density (BMD), and spine X-rays were obtained. A
total of 837 participants attended a follow-up visit in 1997–
2000.
Results PAD defined by an ABI≤0.90 was present in
15.4% of the women and 13.3% of the men. Prevalence
of osteoporosis was significantly higher in women with
PAD compared to women without PAD (p<0.05). During
an average 4-year follow-up, women with PAD had a
significantly higher rate of bone loss than women without
PAD (p=0.05). The associations were no longer significant
after age adjustment. In men, PAD was not associated with
osteoporosis, but men with PAD had lower BMD at the
femoral neck than men without PAD (p=0.03). PAD was
not associated with osteoporotic fractures in either sex.
Conclusion We found a weak and age-dependent association
between PAD and osteoporosis in women but not men. PAD
was not associated with fractures in this community-based
population.
Keywords Osteoporosis.Peripheral artery disease
Introduction
Increased rates of bone loss, osteoporosis, and osteoporotic
fractures have been reported in adults with cardiovascular
disease, suggesting an association between osteoporosis
and atherosclerosis [1–3]. A few studies have suggested an
association between osteoporosis and peripheral arterial
disease (PAD) in women [4–6], but studies in men yielded
inconsistent results [5, 7]. Low bone mineral content at
menopause appears to be a risk factor for increased
cardiovascular disease mortality in later life [8–10]. To
our knowledge, the association of PAD with osteoporotic
fractures has not been reported. We report here a study
examining the association between PAD based on the
ankle–brachial index (ABI), with measures of bone health
assessed by dual energy X-ray absorptiometry (DXA) and
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men and women. The aims of this study were: (1) to
determine whether PAD defined by several ABI cut points
is associated with low bone mineral density (BMD), bone
loss, and/or osteoporotic fractures; (2) to determine whether
PAD can predict BMD loss or incident osteoporotic
fractures; and (3) to determine whether any associations
are independent of age, body mass index (BMI), and other
covariates including smoking, physical activity, alcohol
intake, medication use, lipid levels, blood pressure, renal
function, and diabetes status.
Methods
The Rancho Bernardo Study, a cohort of Caucasian, middle
to upper-middle class, community-dwelling adults in
Southern California, was established in 1972; details of
the initial study have been published [11]. Between 1992
and 1996, approximately 80% (n=1,778) of surviving local
residents participated in a research clinic visit. A total of
527 men and 805 women, aged 30 to 97 (mean age=73.8,
SD=9.2) completed standardized questionnaires about
medical history, including osteoporotic fractures and were
examined for ABI and BMD. Seventy-seven percent (n=
1,096) of surviving participants returned for a follow-up
visit in 1997–2000. Of these, 322 men and 515 women had
BMD measurement repeated and were queried about
interim OP fractures. Main reasons for nonparticipation
among survivors included moving away, being too sick or
too busy, or being institutionalized.
Data on the following variables were collected at
baseline: age, height, weight, alcohol intake (drink alcohol
three or more times/week), smoking status (current vs. not
current), medications, physical activity (exercise three or
more times/week), history of bone fractures and diabetes,
fasting lipid levels, renal function, intermittent claudication
(a symptom of severe PAD) based on the Rose question-
naire [12], BMD, and ABI (see below). Radiographs of the
thoracic and lumbar spine were obtained and read by a
single skeletal radiologist. Serum creatinine levels were
measured by Smith Kline Beecham clinical laboratories.
Creatinine clearance was calculated by the modified
Cockcroft–Gault formula: [140 − age (in years)] × weight
(in kilograms) / [72 × serum creatinine (mg/dl)] and
corrected for body surface area. For women, the product
was multiplied by 0.85 (a correction factor recommended
for females) [13].
BMD was measured at the hip and lumbar spine using
DXA (Hologic QDR model 1000; Hologic Inc., Bedford,
MA, USA). Total hip BMD included the greater trochanter,
femoral neck, and intertrochanter area. Bone densitometers
were calibrated daily and measurements maintained within
the manufacturers’ precision standards. The BMD T scores
were expressed in standard deviations using the peak bone
mass from the manufacturer’s reference population. Oste-
oporosis was defined as BMD at the femoral neck or the
hip ≥2.5 standard deviations (SD) below the young adult
mean.
Incident fractures and repeated BMD were determined
at a follow-up visit an average of 4 years (range 1–7)
later. Bone change was calculated as BMD percent change
per year. Non-vehicular accident fractures occurring after
age 45 were classified as osteoporotic. Ninety-five percent
of self-reported fractures were confirmed by radiology
reports.
ABI measurements
The ABI is a simple noninvasive method to assess the
presence and extent of atherosclerosis in the lower leg.
Participants were rested in the supine position for 5 min,
after which a specially trained and certified nurse used a
handheld Doppler flowmeter attached to a mercury sphyg-
momanometer cuff to measure the blood pressure in each
arm (brachial artery) and leg (posterior tibial artery).
Systolic blood pressure was recorded once for each arm
and twice for each leg. The ABI was calculated for each leg
by dividing the higher systolic pressure of the leg by the
systolic blood pressure in the arm. The lower of these two
ABIs was used to define participants with PAD. The
sensitivity and specificity of an ABI>0.9 for PAD are
80% and 95%, respectively [14]. One man and one woman
had an ABI>1.3, consistent with noncompressible arteries
and were excluded from the analyses.
Statistical analyses
Descriptive analyses are expressed as mean (SD) or
percentages and were compared using the Student t test or
chi-square tests as appropriate. Analysis of covariance was
used to calculate sex- and site-specific mean BMD levels
and mean annual percent change in BMD stratified by PAD
status (defined as ABI>0.9 vs. ABI≤0.9 and using
literature suggested cut-points of <0.90, 0.90–1.00, 1.01–
1.10, and >1.10) [15]. Risk factors previously shown to be
associated with BMD in this cohort (age, BMI, use of
calcium supplements (yes/no), exercise (≥3/week), renal
function, and hormone therapy use (current vs. not) as well
as classic risk factors for atherosclerosis and PAD (smok-
ing, hypertension, systolic blood pressure, TC/HDL ratio,
and diabetes) were examined in separate and multivariate
models. Adjustments for other possible confounders in-
cluding use of thiazides, vitamin D supplements, and lipid-
lowering medication did not change any of the results and
were not included in the final models. Adjusted multiple
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2074 Osteoporos Int (2009) 20:2071–2078logistic regression was used to assess the contribution of
PAD status to the prevalence and incidence of osteoporotic
fractures. Because there were important differences in the
prevalence of osteoporosis, bone loss, and PAD between
men and women, all analyses were presented stratified by
sex. All statistical tests were two-tailed, with statistical
significance defined as p<0.05. SPSS (SPSS Inc., SPSS
Base 15 for Windows User’s Guide) and SAS (SAS
Institute SAS User’s Guide, Version 8.2) were used for
analysis.
Results
The mean age was 74 years (SD=9, range 30 to 97). At
baseline, PAD defined by an ABI≤0.90 was present in
15.4% of women and 13.3% of men. No participants
reported intermittent claudication. Table 1 shows that,
compared to those without PAD, men and women with
PAD were older (p<0.001), more likely to have higher SBP
(p≤0.03) and lower levels of creatinine clearance (p≤0.01),
more likely to be sedentary (p≤0.02), less likely to report
calcium supplementation (p<0.02), and more likely to have
chronic kidney disease defined as CrCl<60 ml/min/1.73 m
2
(p=0.02). Additionally, women with PAD were less likely
to be current users of estrogen therapy (p=0.01), had a
higher TC/HDL ratio (p=0.003), and were less likely to
report alcohol intake (p=0.02) than women without PAD.
Men (but not women) with PAD were more likely to be
current smokers (p=0.001) than men without PAD.
Participants who did not return for the follow-up visit
were older (75.8 vs. 72.6 years, p<0.01), had lower mean
ABI (1.02 vs. 1.06, p<0.01) and were more likely to have
categorically defined PAD (19.5%1 vs. 11.7% p<0.001)
when compared to participants who returned for the follow-
up visit. They were also more likely to have total hip and
femoral neck osteoporosis (18.4% vs. 12.2%, p=0.002 and
49.5% vs. 42.1%, p=0.03, respectively) but had similar
prevalence of vertebral and nonvertebral osteoporotic
fractures.
The BMD, BMD change, and prevalent and incident
osteoporotic fractures are shown in Table 2. The only
statistically significant differences were that men with PAD
had lower BMD at the femoral neck (p=0.03), and women
with PAD had a significantly higher rate of bone loss at the
hip (−0.86%/year vs. −0.52%/year, p=0.05) when com-
pared to men and women without PAD. Compared to
women without PAD, the prevalence of osteoporosis by
WHO (T score) criteria at the femoral neck and hip was
significantly higher in women with PAD (59.2% vs. 48.5%
and 25.4% vs. 17.6%, respectively, p<0.05). There were no
differences in categorically defined osteoporosis prevalence
by PAD status in men. All significant associations between
PAD and bone were no longer significant after adjusting
for age. Further adjustments for BMI, exercise, smoking
status, cholesterol/HDL ratio, hypertension, creatinine
clearance, and diabetes did not materially change any of
the results. Stratifying ABI by quartiles or using three
categories (tertiles or ABI<0.9, 0.9–1.1, and >1.1) did not
change the significance of the associations (results not
shown).
At baseline, 143 participants had reported at least one
clinical vertebral fracture and 126 reported a nonvertebral
fracture. Incident nonvertebral fractures were reported by
70 participants. More women than men had a vertebral and/
or nonvertebral osteoporotic fracture at baseline (13% vs.
8% and 12% vs. 7%, respectively; all p<0.01), but there
were no sex difference in the incidence of nonvertebral OP
fractures (8.2% in men vs. 9.0% in women, p=0.72).
Logistic regression models (Table 3) show that PAD was
not associated with prevalent or incident OP fractures in
men or women. After a mean follow-up of 4 years (SD=
0.9), BMD was the only independent variable associated
with osteoporotic fractures for both sexes with higher BMD
Nonvertebral fractures Vertebral fractures Incident nonvertebral fractures
Men (n=34) (n= 42) (n=26)
ABI<0.9 1.25 (0.36–4.37) 3.33 (0.74–14.9) 1.52 (0.30–7.45)
Age (years) 0.97 (0.92–1.02) 1.01 (0.97–1.07) 1.01 (0.94–1.07)
BMI 1.01 (0.89–1.15) 1.01 (0.88–1.13) 1.16 (1.00–1.35)
Hip BMD 0.18 (0.01–3.20) 0.03 (0.002–0.49)** 0.004 (0.00–0.20)**
Women (n=92) (n=101) (n=44)
ABI<0.9 0.87 (0.47–1.63) 1.47 (0.75–2.87) 0.84 (0.31–2.26)
Age (years) 1.00 (0.97–1.04) 1.06 (1.02–1.10)** 0.98 (0.93–1.03)
BMI 0.99 (0.92–1.07) 1.13 (1.05–1.21)* 1.05 (0.95–1.15)
Hip BMD 0.07 (0.01–0.58)** 0.005 (0.01–0.04)** 0.12 (0.01–2.30)
Current estrogen 1.19 (0.70–2.03) 1.62 (0.92–2.86) 1.05 (0.49–2.22)
Table 3 Odds ratio for predic-
tors of osteoporotic fractures in
men and women
Rancho Bernardo Study 1992–
1996 and 1999–2002. Multivari-
able models also included current
smoking, lack of exercise, hyper-
tension, diabetes, TC/HDL, and
kidney disease—all variables were
not significant predictors of
fractures
*p<0.05, **p≤0.01
Osteoporos Int (2009) 20:2071–2078 2075associated with fewer prevalent nonvertebral and vertebral
fractures in women and prevalent vertebral fractures and
incident nonvertebral fractures in men. In women, age and
BMI were also associated with clinical vertebral fractures.
Discussion
In this study, PAD defined as an ABI≤0.9 was not
independently associated with BMD, osteoporosis, or
osteoporotic fractures in either sex. In accord with other
studies, hip BMD was an independent risk factor for
vertebral and nonvertebral fractures in both sexes [16–20].
The increasing odds for a vertebral fracture with increasing
BMI observed in women in this study were unexpected and
could be spurious. A high BMI has been shown to protect
the bone, and low BMI is a risk factor for osteoporotic
fractures in weight-bearing appendicular bones [21, 22], but
the effect of BMI on the spine has been less consistent.
Three large population-based studies found a weak [23]o r
absent association [24, 25] between bodyweight and
prevalent or incident vertebral fracture in both sexes. In
contrast, increasing bodyweight was associated with a
reduced risk of a first vertebral fracture in women in the
Study of Osteoporotic Fractures [26]. We were unable to
examine incident vertebral fractures because X-rays were
not obtained in the follow-up visit.
Previous studies examining the cross-sectional associa-
tion between osteoporosis and PAD have reported weak or
absent associations. Vogt and collaborators [27] studied
1,292 women from the Study of Osteoporotic Fractures
with a mean age of 71 years and found an association
between the ABI and BMD at the femoral neck, but the
association was not independent of BMI. Van der Klift and
collaborators [5] studied 3,053 women and 2,215 men aged
60 to 70 years from the Rotterdam Study and found that PAD
was associated with lower BMD at the femoral neck in women
but not in men, with no associations found between PAD and
lumbar spine in either sex. Mangiafico and collaborators [4]
reported an 18.2% prevalence of PAD in women with
osteoporosis versus 3.8% in women with normal BMD;
lower BMD at the femoral neck was associated with PAD
independent of BMI, smoking, lipid levels, blood pressure, or
other risk factors for atherosclerosis.
Different results have been reported from recent small
case-control studies of patients with advanced arterial
disease. Pennisi and collaborators [28] studied 36 women
with advanced atherosclerosis of the carotid and/or femoral
artery and 30 age-matched controls and reported that
carotid or femoral plaque measured by ultrasonography
was associated with both regional and total body BMD.
Laroche and collaborators [7] studied 18 men with
symptomatic arterial disease of the lower limbs and found
a decrease in bone mineral content in the more affected leg
compared with the less affected leg. Ischemia was postu-
lated to be the cause of local bone loss in these men with
asymmetric PAD. Fahrleitner-Pammer and collaborators
[29] examined 95 men and women with angiographically
confirmed PAD and 44 controls and found that PAD was
associated with lower BMD and increased bone resorption
independent of BMI and other known confounders. In our
study, the associations between PAD and BMD were weak
and age-dependent. It is likely that people with mild or
asymptomatic arterial disease do not have sufficient
compromised circulation to impair bone health, unlike
those in the studies above.
Overall, these data suggest that severe atherosclerosis
that compromises blood flow to the lower limb may cause
bone loss but that mild usually subclinical PAD does not. In
a recent prospective study of 963 postmenopausal women,
Tanko and collaborators [30] reported that severity of
atherosclerosis in the aorta was inversely associated with
BMD at the hip but not at the radius or spine and concluded
that the association of aortic calcification with BMD is site-
specific. The authors speculated that aortic calcification
may influence blood flow to the distal regions affecting
blood supply to the hip [31]. In a large prospective study of
3,998 Chinese men and women aged 65 to 92 years, Wong
and collaborators [32] reported an association between PAD
and BMD at the hip, but, as in our study, this association
was not independent of age, sex, bodyweight, and other risk
factors. There is evidence that arterial calcification is a
strong predictor of low bone mass and fragility fractures,
but to our knowledge, no study has examined the
association of PAD with prevalent and incident osteoporotic
fractures. Patients with PAD may experience difficulties
with mobility and proprioception increasing their likelihood
of falls and fractures. Although we found no association
between PAD and prevalent or incident osteoporotic
fractures, there were relatively few fractures limiting our
power.
Our study has other limitations. The Rancho Bernardo
Study population is almost entirely Caucasian and middle
to upper-middle class; results might not generalize to other
populations. However, the prevalence of PAD was 15% in
women and 13% in men—similar to PAD prevalence
reported by other comparable studies [5]. Participants’
mean age at baseline was 74 years, and participants who
did not return for the follow-up visit were older and more
likely to have PAD and osteoporotic fractures. PAD was not
assessed by angiography, but others have shown a high
validation of ABI with angiographic studies [33]. Finally,
the mean follow-up for bone loss and incident fractures was
only 4 years, and the incidence of OP fractures was low. A
longer follow-up may be needed to better assess the role of
PAD in the incidence of OP fractures.
2076 Osteoporos Int (2009) 20:2071–2078In conclusion, in these relatively healthy older adults,
associations were weak and entirely explained by age.
Longer, larger prospective studies are needed to determine
whether asymptomatic ABI independently predicts bone
loss and fractures in older adults. Given the increasing age
in the USA, it is important to examine the association
between these two chronic conditions and potential common
underlying pathophysiologic mechanisms.
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